naproxen 250 mg

DRUG2 trials

Sponsors

Ardea Biosciences, Inc., Massachusetts General Hospital

Conditions

Gout

Phase 1

NSAID Drug Interaction Study

CompletedNCT01884272

Ardea Biosciences, Inc.Gout

Start: 2013-06-30End: 2013-10-31Updated: 2013-11-08

Phase 4

Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

RecruitingNCT04875702

Massachusetts General HospitalGout

Start: 2024-02-22End: 2028-10-31Target: 650Updated: 2025-09-25